|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.21 EUR | -4.09% |
|
+10.00% | +78.63% |
| Apr. 05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| Mar. 28 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apontis Pharma AG provided revenue guidance for the year 2022. For the year, the Executive Board confirms its forecast of an increase in revenues of 8% to EUR 55.3 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +28.79% | 676B | |
| +24.54% | 559B | |
| -5.84% | 356B | |
| +15.75% | 320B | |
| +4.32% | 286B | |
| +3.11% | 213B | |
| +0.73% | 207B | |
| -8.75% | 199B | |
| -10.00% | 147B |
APONTIS PHARMA AG 
